Nurse Practitioner, Family · Orlando, FL
NPI
1770971343
Since 2015
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
1646 33rd St, Suite 101
Orlando, FL, 32839
Phone (407) 409-8118
Groups this clinician bills Medicare through
Medicare paid, 2024
$11K
210 services
Medicare patients, 2024
103
Average age 68
Drug cost, 2024
$6.6M
6,633 prescriptions
Company payments, 2025
$3,094
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alissa G Ledgerwood was code 99214 (office e&m - established), 119 times for 98 patients. In total Alissa G Ledgerwood billed 210 services in 8 codes, and Medicare paid $11K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-05-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 119 | 98 | $82.88 | $9,863 |
By year: 2022 $29K for 349 services; 2023 $25K for 319 services; 2024 $11K for 210 services.
Medicare prescription drug claims, 2024
In 2024, the drug Alissa G Ledgerwood prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 771 prescriptions and refills. In total Alissa G Ledgerwood wrote 6,633 Medicare prescriptions that cost $6.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 771 | 1,266 | 232 | $18K |
| Prednisone Generic | 720 | 915 | 250 | $3,248 |
| Methotrexate Methotrexate Sodium | 572 | 856 | 170 | $9,344 |
| Gabapentin Generic | 394 | 480 | 98 | $4,646 |
| Leflunomide Generic | 324 | 576 | 95 | $18K |
| Pregabalin Generic | 220 | 227 | 56 | $13K |
| Tizanidine Hcl Generic | 219 | 292 | 87 | $2,314 |
| Tramadol Hcl Generic | 197 | 197 | 58 | $1,508 |
| Duloxetine Hcl Generic | 190 | 301 | 55 | $2,631 |
| Pilocarpine Hcl Generic | 179 | 286 | 48 | $14K |
| Humira(Cf) Pen Adalimumab | 158 | 160 | 39 | $1.1M |
| Mycophenolate Mofetil Generic | 149 | 218 | 51 | $18K |
| Azathioprine Generic | 139 | 191 | 35 | $2,919 |
| Enbrel Sureclick Etanercept | 138 | 139 | 34 | $1.0M |
| Rinvoq Upadacitinib | 136 | 136 | 22 | $921K |
Brand drugs: 1,121 claims; generic drugs: 5,382 claims; opioid claims: 255.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alissa G Ledgerwood $3,094 ($3,094 in general payments such as food, travel and fees) from 20 companies. The largest payer was Amgen Inc. with $404.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 22 | $404 |
| Abbvie Inc. ABBV | 18 | $355 |
| Pfizer Inc. PFE | 33 | $323 |
| UCB, Inc. UCB.BR | 15 | $307 |
| Novartis Pharmaceuticals Corporation NVS | 18 | $299 |
| Janssen Biotech, Inc. JNJ | 11 | $237 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $222 |
| Genzyme Corporation SNY | 7 | $207 |
| Ferring Pharmaceuticals Inc. | 5 | $130 |
| Mallinckrodt Hospital Products Inc. | 4 | $124 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.